Vinay Prasad to exit CBER as FDA group director
By Catherine Eckford (European Pharmaceutical Review)
CSL breaks ground on $1.5bn Illinois plasma therapy facility expansion
By Catherine Eckford (European Pharmaceutical Review)
Biogen/Stoke’s zorevunersen hailed as potential first disease-modifying drug for rare epilepsy
By Catherine Eckford (European Pharmaceutical Review)
Sanofi gains access to first-in-class JAK inhibitor through $1.5bn licensing deal
By Catherine Eckford (European Pharmaceutical Review)
Transformer-multimodal spectral imaging (TMSI): a novel, AI-driven alternative microbiological method…
By Alexandre Banon, Ali Keshavarzi, Arthur Vivé, Emilia Humeau, Ludovic…
Applying AI to enhance drug formulation and development
By Sanjay Konagurthu (Thermo Fisher Scientific)































